15 results
DEF 14A
TSBX
Turnstone Biologics Corp
22 Apr 24
Definitive proxy
4:28pm
power with respect to all shares that they beneficially own, subject to applicable community property laws.
In computing the number of shares
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
as the Community code on medicinal products. Regulation (EC) No. 1394/2007 establishes specific rules concerning the authorization, supervision … , whether related to our therapies or those of our competitors, our product candidates may not be accepted by the general public or the medical community
10-Q
2023 Q2
TSBX
Turnstone Biologics Corp
1 Sep 23
Quarterly report
4:39pm
or those of our competitors, our product candidates may not be accepted by the general public or the medical community and potential clinical trial … marketing approval, it may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community
424B4
zejqw2 ew9w
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
5w747xf1kk8cttdu
23 Jun 23
IPO registration (amended)
9:49pm
S-1/A
EX-4.1
0iqkmsz
23 Jun 23
IPO registration (amended)
9:49pm
S-1
EX-10.9
khzlc
12 Jun 23
IPO registration
4:28pm
S-1
km1uc ayfj
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.8
4g4fqmmb20p9uhl8
12 Jun 23
IPO registration
4:28pm
DRS
EX-10.9
8h99b0zmsv eo
15 May 23
Draft registration statement
12:00am
DRS
EX-10.8
qxq1er5u gox5yt2azt
15 May 23
Draft registration statement
12:00am
DRS
shvvvk6 1qs4
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next